SCHEMBL3762352

SCHEMBL3762352

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3ccnc(-c4cccc(C(=O)N5CC(N)C5)c4)c3)c2C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.37
MTOR P42345 2/20 0.37
KDM4E B2RXH2 1/20 0.35
PLK4 O00444 1/20 0.34
JAK2 O60674 1/20 0.34
MAP4K4 O95819 1/20 0.34
ROS1 P08922 1/20 0.34
FGFR1 P11362 1/20 0.34
FLT1 P17948 1/20 0.34
MARK3 P27448 1/20 0.34
FLT4 P35916 1/20 0.34
KDR P35968 1/20 0.34
FLT3 P36888 1/20 0.34
CLK2 P49760 1/20 0.34
CSNK1G2 P78368 1/20 0.34
MAP4K2 Q12851 1/20 0.34
ROCK1 Q13464 1/20 0.34
NTRK3 Q16288 1/20 0.34
MINK1 Q8N4C8 1/20 0.34
AURKB Q96GD4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3762139 0.95 MTOR (0.36) PIK3CAMTORKDM4EPLK4JAK2
SCHEMBL3763824 0.95 MTOR (0.36) PIK3CAMTORKDM4EPLK4JAK2
SCHEMBL3757676 0.95 MTOR (0.36) PIK3CAMTORKDM4EPLK4JAK2
SCHEMBL3765983 0.93 PIK3CA (0.38) PIK3CAMTORKDM4EPLK4JAK2
SCHEMBL3765061 0.91 CCNT1 (0.36) PIK3CAMTORKDM4EPLK4JAK2
SCHEMBL3763716 0.91 ATR (0.40) PIK3CAMTORKDM4EPLK4JAK2
SCHEMBL3756825 0.90 ATR (0.41) PIK3CAMTORKDM4EPLK4JAK2
SCHEMBL3761420 0.90 PIK3CA (0.36) PIK3CAMTORKDM4EPLK4JAK2
SCHEMBL3760654 0.90 PIK3CA (0.36) PIK3CAMTORKDM4EPLK4JAK2
SCHEMBL3766668 0.90 MTOR (0.40) PIK3CAMTORKDM4EPLK4JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CA 3/4885MTOR 7/4885KDM4E 1014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.